Xenin-25 dosing & administration
The Natural Incretin Helper Peptide That Enhances Glucose Control and Insulin Response
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Dosing
How much do I take?
Intravenous infusion: Delivered straight into a vein through a drip (IV), done by a clinician.
Bioavailability Complete (about 100%) — delivered straight into the bloodstream.
4 pmol/kg/min (after a brief higher loading ramp of 10.8→7.7→5.6 pmol/kg/min over the first 10 min)
Frequency
Continuous infusion
Duration
Up to ~4 hours (during glucose clamp)
Human IV infusion dose used to amplify GIP-mediated insulin secretion during a hyperglycemic clamp [5]. Research use only.
Timing
Best time to take
Xenin-25 is administered intravenously in a clinical setting. Timing is determined by your healthcare provider based on the treatment protocol and your medical needs.
With food?
IV administration of Xenin-25 is not dependent on meal timing. Your healthcare team will provide specific instructions regarding food and fluid intake around treatment sessions.
If stacking
Xenin-25 should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
- You've tolerated the current dose for the recommended period without significant side effects
- Therapeutic goals haven't been met at the current dose level
- Your healthcare provider recommends dose escalation based on your response
- Lab work or clinical assessments support a higher dose
Decrease if
- Side effects are bothersome or impacting daily life despite management strategies
- You experience any signs of an adverse reaction
- Lab results indicate the need for dose reduction
- Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- Therapeutic goals being met with minimal side effects
- Stable and consistent response to treatment
- Lab values or clinical markers trending in the right direction
- Good tolerance with manageable or absent side effects
Administration
How do I use it?
Reconstitution
What you need
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Storage
Before reconstitution
Store Xenin-25 in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Xenin-25 should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation — discard the vial
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Intravenous (IV)—rotate sites if applicable
Maintain a consistent schedule for optimal results with Xenin-25. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is it safe?
Side effects
Commonly reported: Gastrointestinal Discomfort, Nausea, Headache
Less common: Injection Site Reactions, Mild Fatigue
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Xenin-25
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Xenin-25 should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Flagged pairings
- Insulin (without professional medical monitoring) — Risk of hypoglycemia without proper glucose monitoring and dose adjustment
Published research
What the studies show
Gong B, et al. · 2025
Engineered xenin peptides show extended half-lives (from minutes to hours) and improved effectiveness in animal diabetes models through better insulin secretion and blood sugar control. Multi-hormone combinations combining xenin with other digestive hormones show promising synergistic effects, though human clinical trials are still needed to confirm safety and effectiveness in treating metabolic diseases.
Craig SL, et al. · 2021
Since its 1992 discovery, xenin has shown multiple benefits for diabetes management including enhanced insulin secretion, appetite suppression, and restoration of GIP sensitivity in Type 2 diabetes. This K-cell hormone holds significant promise as a diabetes therapy, especially when combined with other gut hormones in new dual and triple hormone treatments.
English A, et al. · 2020
When GIP and xenin work together on fat cells, they have unique combined effects that differ from their individual actions—they reduce fat buildup while increasing glucose uptake and regulating lipolysis. This suggests the two K-cell hormones have evolved to work as a coordinated team for metabolic regulation, with important implications for combination therapies in metabolic disorders.
Craig SL, et al. · 2021
Boosting xenin levels alongside DPP-IV inhibitors like sitagliptin significantly enhances diabetes treatment effectiveness in animal models. This combination approach suggests that targeting xenin upregulation could unlock new ways to improve existing diabetes medications and provide better glucose control for patients.
Wice BM, Reeds DN, Tran HD, et al. · 2012
Head to head
Xenin-25 compared
Want the full picture?
The complete Xenin-25 research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.